3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is increasingly attracting clinical scrutiny due to initial evidence suggesting distinct biological characteristics. Preliminary research indicate that 3-HPC may possess separate effects on the brain system, possibly contributing to some of the unanticipated symptoms associated wi